Clinical trials
Completed Aortic Aneurysm, Abdominal trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
82 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 9 |
| 2009 | 5 |
| 2010 | 5 |
| 2011 | 7 |
| 2012 | 4 |
| 2013 | 8 |
| 2014 | 6 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 4 |
| 2020 | 3 |
| 2021 | 2 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 82 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endologix | 10 |
| Cook Group Incorporated | 5 |
| Cook Research Incorporated | 5 |
| Medtronic Cardiovascular | 4 |
| North Karelia Central Hospital | 3 |
| The Cleveland Clinic | 3 |
| Assistance Publique Hopitaux De Marseille | 2 |
| Central Hospital, Nancy, France | 2 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 2 |
| Cordis US Corp. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aortic Aneurysm, Abdominal | 82 |
| Aneurysm | 10 |
| Aortic Aneurysm | 6 |
| Iliac Aneurysm | 5 |
| Aortic Aneurysm, Thoracoabdominal | 3 |
| Carotid Stenosis | 3 |
| Endoleak | 3 |
| Vascular Diseases | 3 |
| Aortic Aneurysm, Thoracic | 2 |
| Aortic Diseases | 2 |
Trials
Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.